C12Y 201/01125
Histone-arginine n-methyltransferase
Official title: Histone-arginine N-methyltransferase (2.1.1.125)
C12Y201/01125 (Histone-arginine n-methyltransferase) appears on 6 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 9
- Assignees
- 4
- Inventors
- 12
- Latest grant
- 30 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
By publication year.
Recent patents
- Arginine methyltransferase inhibitors and uses thereof30 Nov 2021US 11,185,531 B2Epizyme, Inc.
- Arginine methyltransferase inhibitors and uses thereof28 Apr 2020US 10,632,103 B2Epizyme, Inc.
- Inhibition of histone methyltransferase for cardiac reprogramming20 Nov 2018US 10,130,637 B2Duke University
- Arginine methyltransferase inhibitors and uses thereof8 Aug 2017US 9,724,332 B2Epizyme, Inc.
- Arginine methyltransferase inhibitors and uses thereof1 Sep 2015US 9,120,757 B2Epizyme, Inc.
- Arginine methyltransferase inhibitors and uses thereof17 Sep 2020US 2020/0289469 A1Epizyme, Inc.
- Inhibition of histone methyltransferase for cardiac reprogramming27 Jun 2019US 2019/0192533 A1Duke University
- Arginine methyltransferase inhibitors and uses thereof11 Oct 2018US 2018/0289671 A1Epizyme, Inc.
- Arginine methyltransferase inhibitors and uses thereof30 Jun 2016US 2016/0184267 A1Epizyme, Inc.
- Inhibition of Histone Methyltransferase for Cardiac Reprogramming22 Oct 2015US 2015/0297611 A1Duke University
Most cited
By later US patents
- Arginine methyltransferase inhibitors and uses thereof45US 9,120,757 B2Epizyme, Inc. · 2015
- Arginine methyltransferase inhibitors and uses thereof7US 9,724,332 B2Epizyme, Inc. · 2017
- Arginine methyltransferase inhibitors and uses thereof3US 10,632,103 B2Epizyme, Inc. · 2020
- Arginine methyltransferase inhibitors and uses thereof2US 11,185,531 B2Epizyme, Inc. · 2021
- Inhibition of histone methyltransferase for cardiac reprogramming1US 10,130,637 B2Duke University · 2018